REVELATION BIOSCIENCES, INC. 8-K

What Happened Revelation Biosciences, Inc. announced on June 1, 2026 that it prepared and publicly released an updated corporate presentation, which the company posted on its website. A copy of the presentation is attached to the Form 8-K as Exhibit 99.1 and is incorporated by reference. The Form 8-K was signed by Chester S. Zygmont, III, the company’s Chief Financial Officer.

Key Details

• Filing date: June 1, 2026 (Current Report on Form 8-K, Item 8.01).
• Exhibit included: Exhibit 99.1 — Corporate Presentation dated June 1, 2026.
• The presentation is available on the company’s website and is incorporated by reference into the filing.
• No earnings, executive changes, mergers/acquisitions, or other financial results were reported in this filing.

Why It Matters Updated corporate presentations often provide the latest information about a company’s strategy, pipeline, milestones, and investor messaging. Investors should review the attached Exhibit 99.1 for any new disclosures or updates that could affect the company’s outlook or valuation. This 8-K itself does not report financial results or management changes; it simply makes the updated investor materials publicly available.